The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

被引：0

作者：

V. ten Cate

H. ten Cate

F. W. A. Verheugt

机构：

[1] Cardiovascular Research Institute Maastricht,Laboratory for Clinical Thrombosis and Haemostasis

[2] Cardiovascular Research Institute Maastricht,Department of Internal Medicine

来源：

Netherlands Heart Journal | 2016年 / 24卷

关键词：

Atrial fibrillation; Anticoagulants; Stroke; Netherlands; Registries;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

There are over 385,000 cases of atrial fibrillation (AF) in the Netherlands, with over 45,000 new cases each year. Among other things, AF patients are at high risk of stroke. Patients are often prescribed oral anticoagulation, such as vitamin K antagonists (VKA), to mitigate these risks. A recently introduced class of oral anticoagulants, non-vitamin K antagonists (NOAC), is quickly gaining currency in global clinical practice. This study provides insight into the changes these new drugs will bring about in Dutch clinical practice.

引用

页码：574 / 580

页数：6

共 50 条

[1] Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
V. ten Cate
H. ten Cate
F. W. A. Verheugt
Netherlands Heart Journal, 2016, 24 : 768 - 768
[2] The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)
ten Cate, V.
ten Cate, H.
Verheugt, F. W. A.
NETHERLANDS HEART JOURNAL, 2016, 24 (10) : 574 - 579
[3] The Global Anticoagulant Registry in the FIELD - Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands (vol 24, pg 574, 2016)
ten Cate, V.
ten Cate, H.
Verheugt, F. W. A.
NETHERLANDS HEART JOURNAL, 2016, 24 (12) : 768 - 768
[4] Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)
Fox, Keith A. A.
Accetta, Gabriele
Pieper, Karen S.
Bassand, Jean-Pierre
Camm, A. John
Fitzmaurice, David A.
Kayani, Gloria
Kakkar, Ajay K.
Lucas Luciardi, Hector
Gibbs, Harry
Brodmann, Marianne
Cools, Frank
Pereira Barretto, Antonio Carlos
Connolly, Stuart J.
Spyropoulos, Alex
Eikelboom, John
Corbalan, Ramon
Hu, Dayi
Jansky, Petr
Nielsen, Jorn Dalsgaard
Ragy, Hany
Raatikainen, Pekka
Le Heuzey, Jean-Yves
Darius, Harald
Keltai, Matyas
Kakkar, Sanjay
Sawhney, Jitendra Pal Singh
Agnelli, Giancarlo
Ambrosio, Giuseppe
Koretsune, Yukihiro
Sanchez Diaz, Carlos Jerjes
Ten Cate, Hugo
Atar, Dan
Stepinska, Janina
Panchenko, Elizaveta
Lim, Toon Wei
Jacobson, Barry
Oh, Seil
Vinolas, Xavier
Rosenqvist, Marten
Steffel, Jan
Angchaisuksiri, Pantep
Oto, Ali
Parkhomenko, Alex
Al Mahmeed, Wael
Fitzmaurice, David
Hu, D. Y.
Chen, K. N.
Zhao, Y. S.
Zhang, H. Q.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2018, 4 (01) : 27 - 35
[5] Role of cardioversion in the management of non-valvular atrial fibrillation: insights from the GARFIELD-AF registry
Schirripa, V.
Radic, P.
Pieper, K.
Illingworth, L.
Le Heuzey, J. Y.
Jansky, P.
Fitzmaurice, D. A.
Connolly, S.
Cappato, R.
Camm, J.
Atar, D.
Kakkar, A. K.
EUROPEAN HEART JOURNAL, 2018, 39 : 51 - 52
[6] Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
Seelig, J.
Verheugt, F. W. A.
Hemels, M. E. W.
Illingworth, L.
Lucassen, A.
Adriaansen, H.
Bongaerts, M. C. M.
Pieterse, M.
Herrman, J. P. R.
Hoogslag, P.
Hermans, W.
Groenemeijer, B. E.
Boersma, L. V. A.
Pieper, K.
ten Cate, H.
THROMBOSIS JOURNAL, 2020, 18 (01)
[7] Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
J. Seelig
F. W. A. Verheugt
M. E. W. Hemels
L. Illingworth
A. Lucassen
H. Adriaansen
M. C. M. Bongaerts
M. Pieterse
J. P. R. Herrman
P. Hoogslag
W. Hermans
B. E. Groenemeijer
L. V. A. Boersma
K. Pieper
H. ten Cate
Thrombosis Journal, 18
[8] Direct current conversion and clinical events at 1 year in patients with non-valvular atrial fibrillation. The Global Anticoagulant Registry in the FIELD (GARFIELD)
Le Heuzey, J-Y
Goto, S.
Verheugt, F. W. A.
Cools, F.
Rushton-Smith, S. K.
Kayani, G.
Wilkinson, P.
Kakkar, A. K.
EUROPEAN HEART JOURNAL, 2013, 34 : 1045 - 1045
[9] Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation
Lip, Gregory Y. H.
Rushton-Smith, Sophie K.
Goldhaber, Samuel Z.
Fitzmaurice, David A.
Mantovani, Lorenzo G.
Goto, Shinya
Haas, Sylvia
Bassand, Jean-Pierre
Camm, Alan John
Ambrosio, Giuseppe
Jansky, Petr
Al Mahmeed, Wael
Oh, Seil
van Eickels, Martin
Raatikainen, Pekka
Steffel, Jan
Oto, Ali
Kayani, Gloria
Accetta, Gabriele
Kakkar, Ajay K.
Lucas Luciardi, Hector
Gibbs, Harry
Brodmann, Marianne
Cools, Frank
Pereira Barretto, Antonio Carlos
Connolly, Stuart J.
Spyropoulos, Alex
Eikelboom, John
Corbalan, Ramon
Hu, Dayi
Nielsen, Jorn Dalsgaard
Ragy, Hany
Le Heuzey, Jean-Yves
Darius, Harald
Keltai, Matyas
Kakkar, Sanjay
Sawhney, Jitendra Pal Singh
Agnelli, Giancarlo
Koretsune, Yukihiro
Sanchez Diaz, Carlos Jerjes
Ten Cate, Hugo
Atar, Dan
Stepinska, Janina
Panchenko, Elizaveta
Lim, Toon Wei
Jacobson, Barry
Vinolas, Xavier
Rosenqvist, Marten
Angchaisuksiri, Pantep
Parkhomenko, Alex
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (02): : S12 - S20
[10] INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY
Lip, Gregory
Bassand, Jean-Pierre
Fitzmaurice, David
Goldhaber, Samuel
Goto, Shinya
Verheugt, Freek
Turpie, Alexander
Mueller, Iris
Rushton-Smith, Sophie
Kakkar, Ajay
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E670 - E670

← 1 2 3 4 5 →